<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2(8)</volume><submitter>Sharrock KC</submitter><pubmed_abstract>This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and Control, which combined newly collected data from EU/EEA countries along with relevant data from existing sources. Data for 2017 were collected from the EU/EEA countries via an online survey. All countries provided responses. In 2017, most countries reporting data had not reached prevention targets for childhood hepatitis B vaccination and for harm reduction services targeting people who inject drugs (PWID). Four of 12 countries had met the target for proportion of people living with chronic HBV</pubmed_abstract><journal>PLOS global public health</journal><pagination>e0000841</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10022013</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Monitoring progress towards elimination of hepatitis B and C in the EU/EEA.</pubmed_title><pmcid>PMC10022013</pmcid><pubmed_authors>Diaz A</pubmed_authors><pubmed_authors>Veldhuijzen I</pubmed_authors><pubmed_authors>James C</pubmed_authors><pubmed_authors>Ruutel K</pubmed_authors><pubmed_authors>Sharrock KC</pubmed_authors><pubmed_authors>Klavs I</pubmed_authors><pubmed_authors>Maticic M</pubmed_authors><pubmed_authors>Hendrickx G</pubmed_authors><pubmed_authors>Rigoni R</pubmed_authors><pubmed_authors>Korenjak M</pubmed_authors><pubmed_authors>Buti M</pubmed_authors><pubmed_authors>Seyler T</pubmed_authors><pubmed_authors>Fursa O</pubmed_authors><pubmed_authors>Noori T</pubmed_authors><pubmed_authors>Rosinska M</pubmed_authors><pubmed_authors>Peters L</pubmed_authors><pubmed_authors>Schatz E</pubmed_authors><pubmed_authors>Duffell E</pubmed_authors><pubmed_authors>Axelsson M</pubmed_authors><pubmed_authors>Mozalevskis A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Monitoring progress towards elimination of hepatitis B and C in the EU/EEA.</name><description>This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and Control, which combined newly collected data from EU/EEA countries along with relevant data from existing sources. Data for 2017 were collected from the EU/EEA countries via an online survey. All countries provided responses. In 2017, most countries reporting data had not reached prevention targets for childhood hepatitis B vaccination and for harm reduction services targeting people who inject drugs (PWID). Four of 12 countries had met the target for proportion of people living with chronic HBV</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-05T11:30:00.029Z</modification><creation>2025-02-19T02:25:34.225Z</creation></dates><accession>S-EPMC10022013</accession><cross_references><pubmed>36962761</pubmed><doi>10.1371/journal.pgph.0000841</doi></cross_references></HashMap>